# PolyProx Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/polyprox-therapeutics

- Industry: Biotechnology
- Headquarters: Cambridge, UK
- Website: www.polyprox.com
- Total disclosed funding: $5.6M
- Latest round: Seed (Jan 31, 2020)
- Investors on record: 4

## About

Established in 2018 and based in Cambridge, UK, PolyProx Therapeutics is a biopharmaceutical firm that develops Polyproxin™ molecules for the treatment of cancer and neurodegenerative disorders through targeted degradation and removal of abnormal proteins.

## Funding rounds

- Seed, Jan 31, 2020, $1.3M — LifeArc
- Seed, Dec 24, 2018, $4.3M — Cambridge Enterprise, Cambridge Innovation Capital, RT Capital

## Investors

- Cambridge Enterprise — Seed
- Cambridge Innovation Capital (https://capitalatlas.ai/funds/cambridge-innovation-capital) — Seed
- RT Capital — Seed
- LifeArc (https://capitalatlas.ai/funds/lifearc) — Seed